We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Modulator of Regulatory T-Cell Behavior Identified

By LabMedica International staff writers
Posted on 25 May 2015
Print article
Image: Micrograph of human intestine from a patient with an inflammatory disease (Photo courtesy of the University of Manchester).
Image: Micrograph of human intestine from a patient with an inflammatory disease (Photo courtesy of the University of Manchester).
A mechanism has been identified that explains how regulatory T-cells (Treg cells) suppress harmful T-cell responses that can lead to the development of autoimmune diseases such as type I diabetes and rheumatoid arthritis.

Treg cells play a pivotal role in suppressing self-harmful T-cell responses, but how they mediate suppression to maintain immune homeostasis and limit responses during inflammation has not been well understood.

Investigators at the University of Manchester (United Kingdom) examined the role of the integrin alphavbeta8 in the modulation of Treg behavior. They reported in the May 12, 2015, online edition of the journal Immunity that effector Treg cells expressed high amounts of integrin alphavbeta8, which enabled them to activate latent transforming growth factor-beta (TGF-beta).

Working with a mouse model, the investigators showed that specific deletion of integrin alphavbeta8 from Treg cells did not result in the generation of spontaneous inflammatory or autoimmune behavior, suggesting that this pathway was not important in Treg cell-mediated maintenance of immune homeostasis. However, Treg cells lacking expression of integrin alphavbeta8 were unable to suppress pathogenic T-cell responses during active inflammation.

Senior author Dr. Mark Travis, lecturer in inflammation research at the University of Manchester, said, “Regulatory T-cells are already being used in clinical trials where the cells are taken from the patient, multiplied, and then given back to the patient to suppress their illness. By understanding the mechanisms behind how regulatory T- cells work, we could improve on these therapies, which can be potentially useful in conditions ranging from type I diabetes to multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease. This knowledge is vitally important when trying to make regulatory T-cells for therapy. By knowing the importance of this pathway, we can now work to improve the suppressive nature of regulatory T-cells to make them more effective as treatments for disease.”

“It is fascinating that getting rid of just one molecule can have such an impact on the body’s ability to fight disease. Our research is all about how the molecules interlink and react to each other, and in certain situations targeting just one molecule can boost or inhibit a response, said Dr. Travis.”

Related Links:

University of Manchester


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.